Biomimetic platform developed to enhance CAR T cell therapy against leukemia

Chimeric antigen receptor T (CAR T) cell therapy represents a milestone in leukemia treatment. CAR T works by genetically ...
Fierce Biotech

As CAR-T cell therapy gains ground on solid tumors, regulatory red tape hinders progress

A new, highly sensitive cell therapy was able to wipe out three different kinds of solid tumors in mice, an important advance in an area where CAR-T cells have long struggled. But significant ...
GEN

CAR T-Cell Therapy: New Advances Move On Past Setbacks

Chimeric antigen receptor (CAR) T-cell therapy is an innovative cancer treatment that engineers a patient’s own T cells to target and destroy cancer cells. While the field has sparked significant ...
The Manila Times

PolTREG moves forward with the European registration process for TREG therapy in type 1 diabetes

The European Medicines Agency (EMA) has officially qualified PolTREG to submit an application for marketing authorization in the European Union for the PolTREG-T1D cell preparation. GDAŃSK, Poland, ...
Forbes

Overcoming Barriers In Cell-Based Cancer Therapy

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Universal, off‑the‑shelf CAR‑T cell therapies using gene‑edited donor T cells are beginning ...
Forbes

Nobel Winner Shinya Yamanaka: Cell Therapy Is ‘Very Promising’ For Cancer, Parkinson’s, More

Forbes contributors publish independent expert analyses and insights. Juergen Eckhardt leads Bayer’s impact investment unit, Leaps by Bayer. The world woke up 17 years ago to an astounding scientific ...

Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them

USANewsGroup.com News Commentary -- The global cell therapy market is projected to surpass $8.2 billion in 2026, driven by a wave of clinical breakthroughs and manufacturing milestones reshaping ...

PHCbi unveils cell expansion system for research use

LiCellGrow was developed to assist therapy developers in determining the optimal culture conditions during process ...
Science Daily

Stem cell therapy helps AMD patients see again

A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show the treatment is safe and can significantly improve vision, even in severely ...